Advertisement

Person › Details
David Dible (Citigate Dewe Rogerson Ltd.)
Dible, David (Huntsworth 201506 Senior Director Life Sciences at Citigate Dewe Rogerson London)
![]() |
Organisation | Citigate Dewe Rogerson Ltd. |
Group | Huntsworth (Group) | |
![]() |
Product | public relations / investor relations / marcom (services) |
Record changed: 2021-03-19 |
Advertisement

More documents for David Dible
- [1] Transgene S.A.. (6/14/19). "Press Release: Transgene Launches a Rights Issue for an Amount of up to €50 Million [This document must not be distributed, directly or indirectly, in the United States of America, Australia, Canada or Japan]". Strasbourg....
- [2] Oxurion N.V.. (9/10/18). "Press Release: Oxurion NV Announces New Euronext Brussels Stock Ticker “OXUR” and Launch of New Website". Leuven....
- [3] Transgene S.A.. (8/20/18). "Press Release: Transgene Completes the Sale of the Greater China Rights of TG6002 and TG1050 to Tasly Biopharmaceuticals for $48 Million in Newly-Issued Shares". Strasbourg....
- [4] Heptares Therapeutics Ltd.. (1/10/18). "Press Release: Sosei Subsidiary, Heptares, Enters Drug R&D Collaboration with Imperial College London Focused on Multiple GPCR Disease Target Opportunities in the Gastro-intestinal Tract". Tokyo & London....
- [5] Advicenne S.A.. (1/5/18). "Press Release: Partial Exercise of Over-allotment Option. Capital Increase of around €27.8 Million [NOT FOR USA, AUSTRALIA, CANADA OR JAPAN]". Nîmes....
- [6] ThromboGenics N.V.. (12/8/17). "Press Release: Patient Enrolment in Phase II CIRCLE Study Evaluating THR-409 (ocriplasmin) for Non-Proliferative Diabetic Retinopathy (NPDR) Discontinued Due to Slow Recruitment Rate". Leuven....
- [7] Advicenne S.A.. (12/5/17). "Press Release: Advicenne Raises €27 Million in Successful IPO on Euronext Paris [THIS PRESS RELEASE MAY NOT BE PUBLISHED, DISSEMINATED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY TO THE USA, AUSTRALIA, CANADA OR JAPAN]". Nîmes....
- [8] Owlstone Medical Ltd.. (11/27/17). "Press Release: Owlstone Medical’s Breath Biopsy Platform Integrated into GSK’s Phase II Respiratory Disease Clinical Trial". Cambridge....
- [9] Advicenne S.A.. (11/21/17). "Press Release: Advicenne Launches IPO on Euronext's Regulated Market in Paris [NOT FOR USA, AUSTRALIA, CANADA OR JAPAN]". Nîmes....
- [10] ThromboGenics N.V.. (10/20/17). "Press Release: ThromboGenics Business Update – Q3 2017". Leuven....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Advertisement

» top